Company intelligence / Profile preview

Evologic Technologies

Vienna, Vienna, Austria

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Evologic has developed scalable bioprocessing technology to manufacture stable, pure spores of Arbuscular Mycorrhizal Fungi, supporting increased agricultural yield and stress resistance; they are advancing large-scale production methods for novel biological agricultural inputs. The company is also collaborating on commercial-scale manufacturing of Phoma macrostoma, a biological herbicide developed by Agriculture and Agri-Food Canada.

Therapeutic areas: Other
Modalities: Microbial therapyLive biotherapeutic product therapyBiologic
Industry: Agriculture & AgTech

Partnerships

Agriculture and Agri-Food Canada (biological herbicide technology transfer)Calyxt (PCM™ manufacturing partnership)

Beyond the preview

Go deeper on Evologic Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Evologic Technologies.

Explore the full profile